Related Experiment Video

Updated: Jan 28, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K

Dexamethasone Associated With Significantly Shorter Length of Hospital Stay Compared With a Prednisolone-Based

Kristin Bohannon1, Ronda Machen1, Carolyn Ragsdale1

  • 11 Dell Children's Medical Center of Central Texas, Austin, TX, USA.

Clinical Pediatrics
|March 12, 2019
PubMed

Insights

Dexamethasone significantly reduces hospital stays for pediatric asthma exacerbations compared to prednisone. This finding offers valuable insights for managing acute asthma in children.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology
  • Health Services Research

Background:

  • Acute asthma exacerbations are a common reason for pediatric hospitalizations.
  • Corticosteroids are a cornerstone of treatment, but optimal regimens require further study.
  • Comparing dexamethasone and prednisone for mild to moderate exacerbations is clinically relevant.

Purpose of the Study:

  • To compare the efficacy of dexamethasone versus prednisone-based regimens in pediatric patients hospitalized with acute asthma exacerbations.
  • To evaluate the impact of dexamethasone on length of hospital stay.
  • To determine if dexamethasone offers a shorter hospital stay for mild to moderate asthma.

Main Methods:

  • Retrospective chart review of pediatric patients hospitalized with asthma exacerbations between June 2011 and January 2016.
  • Patient identification using International Classification of Diseases (ICD-9 and ICD-10) codes and pharmacy dispense reports.
  • Statistical analysis comparing length of stay between dexamethasone and prednisolone groups, controlling for confounding variables.

Main Results:

  • The median length of hospital stay was shorter in the dexamethasone group (1.31 days) compared to the prednisolone group (1.75 days).
  • Dexamethasone use was associated with a significantly shorter length of stay (Hazard Ratio = 2.5, P < .001).
  • This difference remained significant after adjusting for confounding variables (Hazard Ratio = 1.8, P < .001).

Conclusions:

  • A course of dexamethasone is associated with a significantly shorter length of hospital stay for pediatric patients with mild to moderate acute asthma exacerbations.
  • Dexamethasone represents a potentially more efficient treatment option compared to prednisone-based regimens for this patient population.
  • These findings support the use of dexamethasone in managing pediatric asthma exacerbations to reduce healthcare resource utilization.

Keywords:
corticosteroidslength of staymethylprednisoloneprednisone

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K
Asthma Detection Research Based on Voice Signal Processing and Machine Learning04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

952

Related Concept Videos

Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271